VB Spine Announces Intent to Acquire Exclusive Rights to Augmedics’ Spine Platform VB Spine LLC the largest privately held spine company, today announced it has entered into a definitive agreement to acquire exclusive rights to the xvision Spine System® (xvision) from Augmedics,…
New ECCO data show subcutaneous (SC) infliximab (Remsima™ SC) effectively recaptures and maintains disease control after drug holiday Celltrion, Inc. today announced new data from a post-hoc analysis of the pivotal LIBERTY studies (LIBERTY-CD and LIBERTY-UC), showing that subcutaneous (SC) infliximab…
Genentech Announces Positive Phase III Results for Gazyva in Primary Membranous Nephropathy, Marking a Significant Milestone in This Autoimmune Disease Genentech, a member of the Roche Group announced today that the Phase III MAJESTY study in adults with primary membranous…
Promega Unveils Cellular Target Engagement Technology Aimed at Expanding the Druggable Proteome at SLAS 2026 Promega Corporation is launching a new live-cell target engagement platform that could close a long-standing gap between biochemical and cellular assays for understudied or difficult-to-interrogate proteins.…
KalVista Pharmaceuticals to Present EKTERLY® (sebetralstat) Data at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting KalVista Pharmaceuticals, Inc. today announced the acceptance of three abstracts for presentation at the 2026 American Academy of Allergy, Asthma & Immunology (AAAAI)…
We Are All Sculptra: First-of-its-Kind Galderma Initiative to Demonstrate How Everyone Can Benefit from Sculptra’s Regenerative Properties Galderma the pure-play dermatology category leader, today unveiled We Are All Sculptra, a unique program designed to capture the clinical impact of Sculptra® across nine…
Florida Health Dept. Proposes New Formal Rule to Slash HIV Drug Access for Thousands, Notes AHF The Florida Department of Health (DOH) today published its Notice of Proposed Rule to formally implement sweeping cuts to the State’s AIDS Drug Assistance Program (ADAP),…
Loyal Raises $100M Series C, Led by age1, to Advance the First Canine Longevity Drug Loyal, a clinical-stage animal health company developing lifespan extension drugs for dogs, announced today that it has raised $100M in Series C funding. age1, the…
Natus Sensory Acquires TheraB Medical to Expand Innovation in Neonatal Phototherapy Natus Sensory, a global leader in sensory and newborn care solutions, today announced the acquisition of TheraB Medical, a medical technology company focused on advancing the treatment of neonatal…
Flatiron Health Names New Chief Business, Technology, and Product Leaders Flatiron Health is pleased to announce three significant appointments to its Executive Team, reflecting the critical, enterprise-level responsibilities these leaders have assumed and the company’s evolving direction. Michael Bierl will…
AstraZeneca awards $3.4 million for programs to improve access to healthcare for patients across the US AstraZeneca has proudly awarded $3.4 million to nonprofit organizations in the US through its Accelerate Change Together (ACT) on Health Equity initiative. This effort aims to…
Atlas Oncology Partners Raises $28M Series A to Scale Value-Based Oncology Care Atlas Oncology Partners today announced the closing of its Series A financing. Atlas was founded by Rubicon Founders, a healthcare investment firm focused on building and growing companies…
